Table 2.
Pathologic report form |
---|
Gross finding |
Residual identified tumor: yes/no |
Quadrant of tumor |
Multifocality: yes/no |
Size of residual tumor: xx mm |
Identified clip of marker: yes/no |
Microscopic finding |
Histologic diagnosis: invasive carcinoma, NST |
Histologic grade: I/II/III (tubule score–nuclear grade–mitosis score) |
Size of residual tumor bed: x mm |
Size of the largest residual invasive carcinoma: x mm |
Residual tumor cellularity: % |
Lymphovascular invasion: absent/present |
DCIS component: yes/no |
Total tumor size including DCIS: x mm |
Extensive intraductal component: yes/no |
Type: cribriform/micropapillary/solid/papillary |
Nuclear grade: low/intermediate/high |
Necrosis: absent/present (focal/commedo) |
ER/PR/HER-2 status: optional |
Resection margin |
Invasive carcinoma: absent/present; distance to the closest margin |
DCIS: absent/present; distance to the closest margin |
Tumor bed: absent/present |
Lymph node status |
Number of sentinel lymph nodes |
Number of total axillary lymph nodes |
Number of lymph nodes with macrometastasis |
Size of largest metastasis: mm |
Number of lymph nodes with micrometastasis |
Number of lymph nodes with isolated tumor cells |
Number of lymph nodes with histologic evidence of treatment response but no tumor cells |
Extracapsular extension: yes/no |
NST, no specific type; DCIS, ductal carcinoma in situ; ER, estrogen receptor; PR, progesterone receptor; HER-2, human epidermal growth factor receptor-2.